Showing results (11-20 of 270) with videos related to
Sort By:
Pageof 27
Frontiers in Endocrinology|November 21, 2025
What is the need for adrenalectomy in patients with congenital adrenal hyperplasia in the era of CRF1/ACTH inhibitors?Olga Fedorova, Henrik FalhammarEndocrine Connections|March 23, 2017
Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' diseaseJan Calissendorff, Henrik FalhammarEuropean Journal of Endocrinology|December 20, 2018
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiencyAnna Nordenström, Henrik FalhammarEndocrine|June 18, 2015
Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcomeHenrik Falhammar, Anna NordenströmEndocrine|October 28, 2017
Lugol's solution and other iodide preparations: perspectives and research directions in Graves' diseaseJan Calissendorff, Henrik FalhammarJournal of the Endocrine Society|February 6, 2025
Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical ImplicationsPaola Concolino, Henrik FalhammarMedicina (Kaunas, Lithuania)|January 23, 2020
To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?Jan Calissendorff, Henrik FalhammarEndocrine|August 11, 2019
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndromeShams Y-Hassan, Henrik FalhammarCurrent Opinion in Pediatrics|June 3, 2026
Advances in pharmacological treatment for congenital adrenal hyperplasiaLara E Graves, Henrik FalhammarJournal of Clinical Medicine|August 6, 2020
Cardiovascular Manifestations and Complications of Pheochromocytomas and ParagangliomasShams Y-Hassan, Henrik FalhammarPageof 27